More evidence of sexual transmission of hepatitis C among HIV-positive gay men in the US

Investigators recommend annual testing for HCV in gay men living with HIV

Michael Carter
Published: 14 February 2013

Investigators in the US have found a high incidence of hepatitis C virus (HCV) infection among HIV-positive gay men. Annual incidence was 1.6% – the highest ever seen in research involving HIV-positive gay men in the United States – among patients receiving care at the Fenway Institute in Boston. The study is published in the online edition of Clinical Infectious Diseases.

“This is the highest HCV incidence reported in the United States among HIV-infected MSM [men who have sex with men] to date and suggests that incident HCV is common in this population,” comment the authors. The study’s findings also showed that infections were most likely due to sexual risk behaviour or non-injecting drug use.

Hepatitis C is a blood-borne infection and injecting drug use is a major risk factor for infection.

However, there is accumulating evidence of hepatitis C transmissions not linked to injecting drug use among HIV-positive gay men. These infections appear to be due to traumatic sexual practices such as fisting and non-injecting drug use, especially in the context of group sex.

Much of this evidence comes from Europe. However, hepatitis C infections in the absence of injecting drug use have also been reported among HIV-positive gay men in New York and other US cities. But low rates of baseline screening have made it difficult to accurately assess incidence of hepatitis C among HIV-infected gay men in the US.

The Fenway Institute in Boston provides care to a large number of HIV-positive gay men. The prevalence of self-reported injecting drug use among these patients is low at below 3%. Researchers at the Institute therefore believed their patients offered “a unique opportunity to explore the epidemiology of HCV among a population of patients previously perceived to be at low risk”.

Doctors from the Institute designed a retrospective study involving all HIV-infected men who had at least two appointments at the clinic between June 2008 and June 2009. The authors extracted data from patient records to determine prevalence and incidence of hepatitis C infection between 1997 and 2009. They also examined the factors associated with both prevalent and incident infections.

A total of 1160 HIV-positive gay men were included in the study, and 1059 (91%) had at least one hepatitis C antibody test. Men who reported sex with men as their only risk factor for infection with HIV were more likely to be screened for hepatitis C than men who reported both sex with another man and injecting drug use (p < 0.01). Men with a detectable viral load were also more likely to have a hepatitis C antibody test than patients with an undetectable viral load (p = 0.01).

Initial screening showed that 64 (6%) of men were co-infected with hepatitis C virus.

Of the 995 men who were initially negative for hepatitis C, 616 (62%) did not have a repeat test. Participants were more likely to have a follow-up screen for the infection if their viral load was detectable (p < 0.01).

“This low rate of repeat…testing may in part be due to healthcare provider perceptions that their patients are at low risk for HCV,” suggest the authors.

The 379 men who had a repeat test contributed 1408 person-years of follow-up. In all, 6% became infected with hepatitis C, providing an incidence of 1.6 per 100 person-years.

Injecting drug use was reported by a third of those with prevalent and incident hepatitis C. Non-injecting drug use was reported by 46% of men, and 16% of individuals denied any substance use. Cocaine was the most widely used non-injected drug. The majority of co-infected patients had a history of at least one sexually transmitted infection.

Compared to participants with hepatitis C at baseline, men with incident infections were younger (37 vs 44 years, p < 0.01) and were more likely to have a history of sexually transmitted infections (87 vs 64%, p = 0.04).

“Our findings support the growing body of evidence that the epidemiology of HCV infection may be changing among HIV-infected MSN in the United States,” comment the authors. “In the absence of IDU [injecting drug use], high risk sexual behaviors and non-injecting drug use appear to play an important role in transmission.”

A liver biopsy was performed on 26 co-infected patients. The results showed that 50% had no or very mild fibrosis and 31% had more advanced liver damage or cirrhosis.

Seven men with incident infections underwent hepatitis C therapy and six achieved a sustained virological response. A successful treatment outcome was also achieved by seven of the 15 men with prevalent infection who underwent therapy.

The authors conclude that HIV-positive gay men should be tested annually for hepatitis C. They also recommend that “HIV-infected MSM who use recreational drugs and/or engage in unprotected sex should receive education and services related to sexual risk reduction…preventative interventions are crucial to stemming the ongoing spread of HCV.”


Garg S et al. Prevalent and incident hepatitis C virus infection among HIV-infected men who have sex with men engaged in primary care in a Boston community health center. Clin Infect Dis, online edition, 2013.

Hepatitis information

For more information on hepatitis visit

Infohep is a project we're working on with the World Hepatitis Alliance and the European Liver Patients Association.

Visit >
Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.